Purpose: The aim of the study is to evaluate long-term liver injuries as sinusoidal obstruction syndrome (SOS) and chemotherapy-associated steatohepatitis (CASH) with functional MRI in patients with pancreatic ductal adenocarcinoma (PDAC) after neoadjuvant chemotherapy. Material and Methods: In this prospective study, 10 patients with borderline resectable/locally advanced PDAC underwent a MRI at 1.5T including gradient echo sequence (T2-FFE) before and after 12 weeks from the beginning of neoadjuvant chemotherapy (liposomal irinotecan + fluorouracil/leucovorin + oxaliplatin). Clinical parameters as body mass index, history of diabetes, hypertension and biological parameters including bilirubin levels, AST, ALT, GGT and drug administration dosage were recorded. A single region of interest (ROI) including the whole liver and other 10 ROIs for hepatic segments were reproduced obtaining a T2* mapping for each patient before and after treatment. T2* values were measured and compared with Wilcoxon test. Results: Significant decrease of T2* values was observed after treatment (p < 0.05), demonstrating a lower hepatic oxygenation, especially for II, VII and VIII hepatic segments. For each patient, III segment T2* values were stable. In 3 patients, no significant changes of T2* values were recorded before and after chemotherapy. Conclusion: Liver steatosis and fibrosis interpose with sinusoidal patency. Including T2* mapping in liver MRI protocol may supply estimation of liver functional changes after chemotherapy.

Evaluation of liver injury with MRI after chemotherapy

L. Tomaiuolo;L. Geraci;C. Longo;M. Todesco;D. Autelitano;A. Carli;F. Moro;R. De Robertis;N. Cardobi;Mirko D’Onofrio
2022

Abstract

Purpose: The aim of the study is to evaluate long-term liver injuries as sinusoidal obstruction syndrome (SOS) and chemotherapy-associated steatohepatitis (CASH) with functional MRI in patients with pancreatic ductal adenocarcinoma (PDAC) after neoadjuvant chemotherapy. Material and Methods: In this prospective study, 10 patients with borderline resectable/locally advanced PDAC underwent a MRI at 1.5T including gradient echo sequence (T2-FFE) before and after 12 weeks from the beginning of neoadjuvant chemotherapy (liposomal irinotecan + fluorouracil/leucovorin + oxaliplatin). Clinical parameters as body mass index, history of diabetes, hypertension and biological parameters including bilirubin levels, AST, ALT, GGT and drug administration dosage were recorded. A single region of interest (ROI) including the whole liver and other 10 ROIs for hepatic segments were reproduced obtaining a T2* mapping for each patient before and after treatment. T2* values were measured and compared with Wilcoxon test. Results: Significant decrease of T2* values was observed after treatment (p < 0.05), demonstrating a lower hepatic oxygenation, especially for II, VII and VIII hepatic segments. For each patient, III segment T2* values were stable. In 3 patients, no significant changes of T2* values were recorded before and after chemotherapy. Conclusion: Liver steatosis and fibrosis interpose with sinusoidal patency. Including T2* mapping in liver MRI protocol may supply estimation of liver functional changes after chemotherapy.
liver, chemotherapy, magnetic resonance imaging
File in questo prodotto:
File Dimensione Formato  
s13244-022-01225-4.pdf

accesso aperto

Licenza: Copyright dell'editore
Dimensione 3.32 MB
Formato Adobe PDF
3.32 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1075281
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact